Coagulant Effect and Tolerability of Yeast-Produced Recombinant Batroxobin in Healthy Adult Subjects

ConclusionsA single intravenous injection of r-batroxobin within a dose range of 2.5 –10.0 BU/2.0 mL was well tolerated and resulted in a significant decrease in fibrinogen and prolongation of TT.RegistrationThis study is registered at the Clinical Research Information Service (CRIS,http://cris.nih.go.kr), number KCT0002518.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research